Tagitanlimab, CAS 2417649-97-7

Product Description: Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC)[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Lu S, et al. Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors. Oncologist. 2019 Feb;24(Suppl 1):S21-S30. /[2]Kaplon H, et al. Antibodies to watch in 2023. MAbs. 2023 Jan-Dec;15(1):2153410.

CAS Number: 2417649-97-7

Molecular Weight: N/A

Compound Purity: 100.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99544-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99544-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK